Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Johnson & Johnson Q4 Earnings Loom As FDA Approves Depression Drug: Will Long-Term Weakness Reverse?
Via Benzinga
Exposures Product Safety
Tickers JNJ
FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs
Via Benzinga
Exposures Product Safety
Tickers ATRA
FDA Approves AstraZeneca's Datroway For Pretreated Breast Cancer Patients
Via Benzinga
Exposures Product Safety
Tickers AZN DSKYF DSNKY
FDA Approves Johnson & Johnson's Treatment As First Monotherapy For Treatment-Resistant Depression
Via Benzinga
Exposures Product Safety
Tickers JNJ
Kairos, OS Therapies, AEON See Highest Weekly Spike In Retail Following Among Biotechs: Here's Why
Via Stocktwits
Exposures Product Safety
Tickers AEON KAPA OSTX
Gastroenterology Expert Dr. David L. Diehl Joins Actuated Medical's Medical Advisory Board
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
XRAY Deadline in 7 Days: Kessler Topaz Meltzer & Check, LLP Reminds DENTSPLY SIRONA Inc. (XRAY) Investors of Filing Deadline in Class Action Lawsuit
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
XRAY Deadline in 7 Days: Kessler Topaz Meltzer &amp; Check, LLP Reminds DENTSPLY SIRONA Inc. (XRAY) Investors of Filing Deadline in Class Action Lawsuit
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
Kessler Topaz Meltzer & Check, LLP Notifies Applied Therapeutics, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kessler Topaz Meltzer &amp; Check, LLP Notifies Applied Therapeutics, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT Announcement: Kessler Topaz Meltzer & Check, LLP Encourages Applied Therapeutics, Inc. (APLT) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
DENTSPLY SIRONA Inc. (XRAY) Investors: January 27, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
APLT Announcement: Kessler Topaz Meltzer &amp; Check, LLP Encourages Applied Therapeutics, Inc. (APLT) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
DENTSPLY SIRONA Inc. (XRAY) Investors: January 27, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer &amp; Check, LLP
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
FDA Warns Hologic Over BioZorb Manufacturing Violations
Via Benzinga
Exposures Product Safety
Tickers HOLX
FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation
Via Benzinga
Exposures Product Safety
Tickers AMGN
FDA Approves AstraZeneca's Calquence Combo Therapy For Untreated Mantle Cell Lymphoma
Via Benzinga
Exposures Product Safety
Tickers AZN
APLT DEADLINE ALERT: Applied Therapeutics Investors Are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT DEADLINE ALERT: Applied Therapeutics Investors Are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
ZYN Nicotine Pouches Receive FDA Marketing Approval
Via Benzinga
Exposures Product Safety
Tickers PM
FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease
Via Benzinga
Exposures Product Safety
Tickers LLY
Is Johnson & Johnson Stock Set to Reward Long-Term Holders?
Via MarketBeat
Exposures Product Safety
Tickers ITCI JNJ
Philip Morris Stock Rises On FDA Approval For Zyn Nicotine Pouches: Retail’s Upbeat
Via Stocktwits
Exposures Product Safety
Tickers PM VOO VTI XLP
ImmunityBio Stock Trading Higher On Updates From Bladder Cancer Trials: Details
Via Benzinga
Exposures Product Safety
Tickers IBRX
FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate
Via Benzinga
Exposures Product Safety
Tickers VNDA
APPLIED THERAPEUTICS INVESTOR ALERT: Kaplan Fox Alerts Investors of a Class Action Deadline on February 18, 2024
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APPLIED THERAPEUTICS INVESTOR ALERT: Kaplan Fox Alerts Investors of a Class Action Deadline on February 18, 2024
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Atara Stock Plunges To 3-Month Low After FDA Blocks Blood Cancer Drug: Retail's Buying The Dip
Via Stocktwits
Exposures Product Safety
Tickers ATRA VTI VXF
Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug
Via Benzinga
Exposures Product Safety
Tickers AMD NVS OTLK RHHBY
FDA Bans Red Dye No. 3 Yet To Dismiss AATCLC Lawsuit To Have Menthol In Cigarettes Banned
Via PRLog
Topics Lawsuit
Exposures Financial Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.